Mephedrone, new kid for the chop? AR Winstock, LR Mitcheson, P Deluca, Z Davey, O Corazza, F Schifano Addiction 106 (1), 154-161, 2011 | 426 | 2011 |
Synthetic cannabis: a comparison of patterns of use and effect profile with natural cannabis in a large global sample AR Winstock, MJ Barratt Drug and alcohol dependence 131 (1-2), 106-111, 2013 | 365 | 2013 |
Drugs and the dance music scene: a survey of current drug use patterns among a sample of dance music enthusiasts in the UK AR Winstock, P Griffiths, D Stewart Drug and alcohol dependence 64 (1), 9-17, 2001 | 353 | 2001 |
Examining the profile of high-potency cannabis and its association with severity of cannabis dependence TP Freeman, AR Winstock Psychological medicine 45 (15), 3181-3189, 2015 | 320 | 2015 |
Mephedrone: use, subjective effects and health risks A Winstock, L Mitcheson, J Ramsey, S Davies, M Puchnarewicz, ... Addiction 106 (11), 1991-1996, 2011 | 307 | 2011 |
Use of S ilk R oad, the online drug marketplace, in the United Kingdom, A ustralia and the United States MJ Barratt, JA Ferris, AR Winstock Addiction 109 (5), 774-783, 2014 | 284 | 2014 |
Ketamine: from medicine to misuse K Wolff, AR Winstock CNS drugs 20, 199-218, 2006 | 260 | 2006 |
Safer scoring? Cryptomarkets, social supply and drug market violence MJ Barratt, JA Ferris, AR Winstock International Journal of Drug Policy 35, 24-31, 2016 | 233 | 2016 |
The prevalence and natural history of urinary symptoms among recreational ketamine users. AR Winstock, L Mitcheson, DA Gillatt, AM Cottrell BJU international 110 (11), 2012 | 225 | 2012 |
Up: The rise of nitrous oxide abuse. An international survey of contemporary nitrous oxide use SJ Kaar, J Ferris, J Waldron, M Devaney, J Ramsey, AR Winstock Journal of psychopharmacology 30 (4), 395-401, 2016 | 181 | 2016 |
Areca nut‐abuse liability, dependence and public health A Winstock Addiction biology 7 (1), 133-138, 2002 | 179 | 2002 |
Ecstasy pill testing: harm minimization gone too far? AR Winstock, K Wolff, J Ramsey Addiction 96 (8), 1139-1148, 2001 | 173 | 2001 |
Definitions related to the use of pharmaceutical opioids: Extramedical use, diversion, non‐adherence and aberrant medication‐related behaviours B Larance, L Degenhardt, N Lintzeris, A Winstock, R Mattick Drug and alcohol review 30 (3), 236-245, 2011 | 164 | 2011 |
No smoke without tobacco: a global overview of cannabis and tobacco routes of administration and their association with intention to quit C Hindocha, TP Freeman, JA Ferris, MT Lynskey, AR Winstock Frontiers in psychiatry 7, 184619, 2016 | 162 | 2016 |
Mephedrone: still available and twice the price A Winstock, L Mitcheson, J Marsden The Lancet 376 (9752), 1537, 2010 | 146 | 2010 |
A dependency syndrome related to areca nut use: some medical and psychological aspects among areca nut users in the Gujarat community in the UK AR Winstock, CR Trivedy, K Warnakulasuriya, TJ Peters Addiction Biology 5 (2), 173-179, 2000 | 146 | 2000 |
The NBOMe hallucinogenic drug series: Patterns of use, characteristics of users and self-reported effects in a large international sample W Lawn, M Barratt, M Williams, A Horne, A Winstock Journal of Psychopharmacology 28 (8), 780-788, 2014 | 144 | 2014 |
Vasopressin and oxytocin secretion in response to the consumption of ecstasy in a clubbing population K Wolff, EM Tsapakis, AR Winstock, D Hartley, D Holt, ML Forsling, ... Journal of Psychopharmacology 20 (3), 400-410, 2006 | 144 | 2006 |
Risk of emergency medical treatment following consumption of cannabis or synthetic cannabinoids in a large global sample A Winstock, M Lynskey, R Borschmann, J Waldron Journal of Psychopharmacology 29 (6), 698-703, 2015 | 143 | 2015 |
Moving on from representativeness: testing the utility of the Global Drug Survey MJ Barratt, JA Ferris, R Zahnow, JJ Palamar, LJ Maier, AR Winstock Substance Abuse: Research and Treatment 11, 1178221817716391, 2017 | 141 | 2017 |